{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:07:06Z","timestamp":1790719626074,"version":"4.1.0"},"reference-count":96,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1517\/14740338.7.5.525","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T08:06:38Z","timestamp":1220256398000},"page":"525-538","source":"Crossref","is-referenced-by-count":51,"title":["The safety of clozapine in the elderly"],"prefix":"10.1517","volume":"7","author":[{"given":"Pietro","family":"Gareri","sequence":"first","affiliation":[{"name":"Chair of Pharmacology University \u201cMagna Graecia\u201d of Catanzaro, \u201cMater Domini\u201d University Hospital, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Medicine and Surgery, Department of Experimental and Clinical Medicine, Via T. Campanella 115, 88100 Catanzaro, Italy ; ;"},{"name":"Operative Unit \u201cElderly Health Care\u201d, ASP Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"De Fazio","sequence":"additional","affiliation":[{"name":"Researcher, Chair of Psychiatry University Magna Gr\u00e6cia of Catanzaro, Mater Domini University Hospital, School of Medicine, Clinical Psychiatric Unit, Department of Experimental and Clinical Medicine, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[{"name":"Chair of Pharmacology University \u201cMagna Graecia\u201d of Catanzaro, \u201cMater Domini\u201d University Hospital, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Medicine and Surgery, Department of Experimental and Clinical Medicine, Via T. Campanella 115, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Marigliano","sequence":"additional","affiliation":[{"name":"Chair of Pharmacology University \u201cMagna Graecia\u201d of Catanzaro, \u201cMater Domini\u201d University Hospital, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Medicine and Surgery, Department of Experimental and Clinical Medicine, Via T. Campanella 115, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Fazio","sequence":"additional","affiliation":[{"name":"Chair of Pharmacology University \u201cMagna Graecia\u201d of Catanzaro, \u201cMater Domini\u201d University Hospital, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Medicine and Surgery, Department of Experimental and Clinical Medicine, Via T. Campanella 115, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[{"name":"Full Professor, Chair of Pharmacology University \u201cMagna Graecia\u201d of Catanzaro, \u201cMater Domini\u201d University Hospital, Clinical Pharmacology and Pharmacovigilance Unit, Faculty of Medicine and Surgery, Department of Experimental and Clinical Medicine, Via T. Campanella 115, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,9]]},"reference":[{"key":"e_1_3_1_2_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200623120-00002"},{"key":"e_1_3_1_2_3_1","unstructured":"FDA Public Health Advisory. Deaths with antipsychotics in elderly patients with behavioural disturbances. 11 April 2005. Available from: http:\/\/www.fda.gov"},{"key":"e_1_3_1_2_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323050-00001"},{"key":"e_1_3_1_2_5_1","unstructured":"EMEA. Committee for proprietary medicinal products (CPMP) summary information on referral opinion following arbitration pursuant to article 30 of council directive 2001\/83\/EC for Leponex and associated names 2002. Available from: http:\/\/emea.eu.int"},{"key":"e_1_3_1_2_6_1","unstructured":"WHO Pharmaceuticals Newsletter. Regulatory matters \u2013 clozapine blood monitoring requirements tightened. 2006 no.1 page 1. Available from: http:\/\/www.who.int\/medicinedocs"},{"key":"e_1_3_1_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606409"},{"key":"e_1_3_1_2_8_1","unstructured":"Clozapine. Retrieved from: htpp:\/\/en.wikipedia.org\/wiki\/Clozapine"},{"key":"e_1_3_1_2_9_1","doi-asserted-by":"publisher","DOI":"10.1185\/0300799039117069"},{"key":"e_1_3_1_2_10_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007999709113338"},{"key":"e_1_3_1_2_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199308000-00012"},{"key":"e_1_3_1_2_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199710000-00009"},{"key":"e_1_3_1_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(99)90134-7"},{"key":"e_1_3_1_2_14_1","unstructured":"Novartis Pharmaceuticals. Prescribing Information April 1006. p 36. Avaliable from: http:\/\/www.novartis.ca\/downloads\/en\/products\/clozaril_scrip_e.pdf Retrieved on 2007-06-29"},{"key":"e_1_3_1_2_15_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.2.109"},{"key":"e_1_3_1_2_16_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17215"},{"key":"e_1_3_1_2_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/13651509809115108"},{"key":"e_1_3_1_2_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000085405.08426.73"},{"key":"e_1_3_1_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(99)00050-7"},{"key":"e_1_3_1_2_20_1","first-page":"181","volume":"135","author":"Galeotta","year":"1990","unstructured":"Galeotta G, Paoletti V, Mammarella A, et al. La terapia farmacologica nel paziente anziano. Clin Ter 1990;135:181-92","journal-title":"Clin Ter"},{"key":"e_1_3_1_2_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205063061804"},{"key":"e_1_3_1_2_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00822.x"},{"key":"e_1_3_1_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(97)00070-0"},{"key":"e_1_3_1_2_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908033210507"},{"key":"e_1_3_1_2_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198529040-00003"},{"key":"e_1_3_1_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100226"},{"key":"e_1_3_1_2_27_1","doi-asserted-by":"crossref","unstructured":"Marzolini C Paus E Buclin T et al. Polymorphism in human MDR1 (P-glycoprotein). Recent advances and clinical relevance. Clin Pharmacol Ther 2004;75:13-33","DOI":"10.1016\/j.clpt.2003.09.012"},{"key":"e_1_3_1_2_28_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1010"},{"key":"e_1_3_1_2_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.t01-1-00605.x"},{"key":"e_1_3_1_2_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01821.x"},{"key":"e_1_3_1_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815f4e72"},{"key":"e_1_3_1_2_32_1","unstructured":"CSLS Handbook Search Results. Clozapine and norclozapine: serum\/ plasma. 2005. Available from: www.cs.nsm.gov.au\/csls"},{"key":"e_1_3_1_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92546-6"},{"key":"e_1_3_1_2_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/331442a0"},{"key":"e_1_3_1_2_35_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.35.040195.002101"},{"key":"e_1_3_1_2_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199608000-00014"},{"key":"e_1_3_1_2_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000146622.59764.dd"},{"key":"e_1_3_1_2_38_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060414"},{"key":"e_1_3_1_2_39_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.2.109"},{"key":"e_1_3_1_2_40_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-39980"},{"key":"e_1_3_1_2_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920007780655469"},{"key":"e_1_3_1_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.176"},{"key":"e_1_3_1_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.021"},{"key":"e_1_3_1_2_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006292249"},{"key":"e_1_3_1_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2003.09.010"},{"key":"e_1_3_1_2_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01858.x"},{"key":"e_1_3_1_2_47_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937030-00001"},{"key":"e_1_3_1_2_48_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0108"},{"key":"e_1_3_1_2_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606002-00009"},{"key":"e_1_3_1_2_50_1","unstructured":"Brunello N. Interazioni farmacocinetiche degli antidepressivi. In: Vella G Siracusano A editors. La depressione nell'anziano. Il Pensiero Scientifico Editore: NOOS Rome; 1998;4:16-28"},{"key":"e_1_3_1_2_51_1","first-page":"655","volume":"49","author":"Michielsen","year":"2007","unstructured":"Michielsen PJ, Thunnissen MM, Van Den Bossche B. Clozapine and selective reuptake inhibitors: risks of toxicity. Tijdschr Psychiatr 2007;49:655-9","journal-title":"Tijdschr Psychiatr"},{"key":"e_1_3_1_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.01.010"},{"key":"e_1_3_1_2_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840380424"},{"key":"e_1_3_1_2_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04134.x"},{"key":"e_1_3_1_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200007000-00006"},{"key":"e_1_3_1_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(02)00314-7"},{"key":"e_1_3_1_2_57_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915030-00006"},{"key":"e_1_3_1_2_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199000391-00003"},{"key":"e_1_3_1_2_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000144891.52858.a6"},{"key":"e_1_3_1_2_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"e_1_3_1_2_61_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576"},{"key":"e_1_3_1_2_62_1","first-page":"119","volume":"50","author":"Kleinen","year":"2008","unstructured":"Kleinen JM, Bouckaert F, Peuskens J. Clozapine-induced agranulocytosis and Sweet's syndrome in a 74-year-old female patient. A case study. Tijdschr Psychiatr 2008;50:119-23","journal-title":"Tijdschr Psychiatr"},{"key":"e_1_3_1_2_63_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060319"},{"key":"e_1_3_1_2_64_1","unstructured":"Clinical data launches pharmacogenetic test for clozapine-induced agranulocytosis on schedule. PGxPredict: CLOZAPINE\u2122 2007. Available from: www.clda.com"},{"key":"e_1_3_1_2_65_1","unstructured":"Jeste DV Eastham JH Lohr JB. Treatment of behavioural disorders and psychosis. In: Salzman C editor. Clinical geriatric psychopharmacology Baltimore (MD): Williams & Wilkins; 1998;6:106-49"},{"key":"e_1_3_1_2_66_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000014826.34803.FC"},{"key":"e_1_3_1_2_67_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730010-00005"},{"key":"e_1_3_1_2_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199804000-00010"},{"key":"e_1_3_1_2_69_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.8.1270"},{"key":"e_1_3_1_2_70_1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/ajhp\/53.17.2079","volume":"53","author":"Ghaeli","year":"1996","unstructured":"Ghaeli P, Dufresen RL. Serum triglyceride levels in patients treated with clozapine. Am J Health Syst Pharm 1996;53:2079-81","journal-title":"Am J Health Syst Pharm"},{"key":"e_1_3_1_2_71_1","first-page":"43","volume":"169","author":"Wirshing","year":"1998","unstructured":"Wirshing WC. The new antipsychotic compounds: is a clinical choice algorithm possible? West J Med 1998;169:43-4","journal-title":"West J Med"},{"key":"e_1_3_1_2_72_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"e_1_3_1_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(93)90126-T"},{"key":"e_1_3_1_2_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106221.36344.4d"},{"key":"e_1_3_1_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00100-0"},{"key":"e_1_3_1_2_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200103000-00001"},{"key":"e_1_3_1_2_77_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1709"},{"key":"e_1_3_1_2_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/0004867900027"},{"key":"e_1_3_1_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(96)90054-1"},{"key":"e_1_3_1_2_80_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01773.x"},{"key":"e_1_3_1_2_81_1","unstructured":"Torta R. Prontuario dei farmaci per il Sistema Nervoso Centrale. Turin: Solvay Pharma SPA; 2000"},{"key":"e_1_3_1_2_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31805930e3"},{"key":"e_1_3_1_2_83_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.2.147"},{"key":"e_1_3_1_2_84_1","first-page":"U651","volume":"116","author":"Lim","year":"2003","unstructured":"Lim A, Sivakumaran P, Israel M. Clozapine-associated polyserositis. N Z Med J 2003;116:U651","journal-title":"N Z Med J"},{"key":"e_1_3_1_2_85_1","first-page":"277","volume":"22","author":"Estebanez","year":"2002","unstructured":"Estebanez C, Fernandez Reyes MJ, Sanchez Hernandez R, et al. Acute interstitial nephritis caused by clozapine. Nefrologia 2002;22:277-81","journal-title":"Nefrologia"},{"key":"e_1_3_1_2_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200309000-00007"},{"key":"e_1_3_1_2_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199706000-00024"},{"key":"e_1_3_1_2_88_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401239509149033"},{"key":"e_1_3_1_2_89_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007999709113338"},{"key":"e_1_3_1_2_90_1","first-page":"1269","volume":"167","author":"Wooltorton","year":"2002","unstructured":"Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ 2002;167:1269-70","journal-title":"CMAJ"},{"key":"e_1_3_1_2_91_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040539"},{"key":"e_1_3_1_2_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32819f8f17"},{"key":"e_1_3_1_2_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/0891988707303335"},{"key":"e_1_3_1_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2007.04.025"},{"key":"e_1_3_1_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2004.04.029"},{"key":"e_1_3_1_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4943(01)00137-6"},{"key":"e_1_3_1_2_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00003"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.7.5.525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:05:44Z","timestamp":1770923144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.7.5.525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1517\/14740338.7.5.525"],"URL":"https:\/\/doi.org\/10.1517\/14740338.7.5.525","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}